| Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Why Syndrome X? From Harold Himsworth to the Insulin Resistance Syndrome |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Use of continuous glucose monitoring system in the management of severe hypoglycemia |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide? |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| Three-year efficacy of complex insulin regimens in type 2 diabetes |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| The use of metformin in type 1 diabetes: a systematic review of efficacy |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
| The transtheoretical model of health behavior change |
dean.jenkins |
Oct 13, 2010 9:42:17 PM |
